CluePoints Sponsored RBQMLive Returns for 2025

RBQMLive, taking place on Thursday, September 25th, 2025, is a free virtual event, bringing together the brightest minds in clinical trials to push the boundaries of risk-based quality management (RBQM). The free event will profile discussions on the return on investment of RBQM, the impact of recent regulatory updates and the implementation of AI. RBQMLive, taking place onThursday, September 25th, 2025, is a free virtual event, bringing together the brightest minds in clinical trials to...

RBQMLive, taking place on Thursday, September 25^th, 2025, is a free virtual event, bringing together the brightest minds in clinical trials to push the boundaries of risk-based quality management (RBQM). The free event will profile discussions on the return on investment of RBQM, the impact of recent regulatory updates and the implementation of AI.

Following the success of last year's event, which drew in over 1,500 attendees from more than 290 organizations, RBQMLive 2025 is set to deliver even greater value with fresh opportunities and practical learning.

Highlights from RBQMLive 2025 will include:

Richard Young, Chief Strategy Officer of CluePoints, commented: "CluePoints is proud to be the premier sponsor of the 5^th annual RBQMLive. With the release of the new ICH E6 (R3) guidance, RBQM and integrated data review are now at the forefront of trial operations and regulatory approval. We look forward to hosting this educational event where industry leaders discuss the capabilities of the approach and the future of RBQM."

RBQMLive 2025 takes place virtually on September 25^th.  Visit RBQMLive 2025 to register and view the full agenda.

About CluePoints

CluePoints is the premier Risk-Based Quality Management (RBQM) and Data Quality Oversight Software provider. We are leveraging the potential of Artificial Intelligence using Advanced Statistics and Machine Learning to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the FDA, EMA, and ICH E6 (R3), CluePoints is deployed to support central and on-site monitoring, medical review, quality risk management and to drive a holistic Risk-Based strategy in all trials. Coupled with thought leadership and consulting expertise to aid pre-study risk assessment, identification of risk controls and solution implementation, you now have everything you need to adhere with global regulatory guidance. The result is positive clinical development outcomes, increased operational efficiency, lower costs and reduced regulatory submission risk as part of the industry paradigm shift to RBQM.

View original content:https://www.prnewswire.co.uk/news-releases/cluepoints-sponsored-rbqmlive-returns-for-2025-302564693.html